Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
Stephen Griffin, Associate Professor of Viral Oncology, University of Leeds

COVID drugs: the UK's treatment and prevention options and how vulnerable people are being forgotten

In February 2022, the UK government abandoned its remaining pandemic restrictions in favour of “living with COVID”. This approach relies largely on vaccines protecting people from severe disease.

However, not everyone benefits equally from vaccines. Former “shielders” – clinically vulnerable people at heightened risk from COVID – number over 3.6 million (around 6% of the UK population).

This group includes 500,000 people whose immune systems don’t respond to vaccines, for example due to genetic disorders, blood cancers or immunosuppressive medications.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.